|
Re: A Second Publication Shortlists Resverlogix Clinical Candidate Apabetalone for its Potential COVID-19 Effectiveness Including Reducing Cytokine Storms
|
8
|
Resverlogix Corp.
|
Oct 26, 2020 04:18PM
|
|
Re: Nature Article on the role of Endothelial Cells in COVID 19 - new article
|
8
|
Resverlogix Corp.
|
Jun 02, 2020 09:38PM
|
|
Re: Summary of Proposed BETonMACE2 design and timelines
|
8
|
Resverlogix Corp.
|
Feb 05, 2021 12:50PM
|
|
Re: Still waiting for that BETonMACE CKD sub-study 7 months later
|
8
|
Resverlogix Corp.
|
Jun 12, 2020 01:58PM
|
|
Re: Nature Article on the role of Endothelial Cells in COVID 19
|
8
|
Resverlogix Corp.
|
May 23, 2020 07:58PM
|
|
ORI developments ?? thanks to rndtbl
|
8
|
Resverlogix Corp.
|
Jan 23, 2021 11:45AM
|
|
Re: Exempt Distribution- 2021-04-12
|
8
|
Resverlogix Corp.
|
Apr 14, 2021 01:09PM
|
|
The more, the merrier
|
9
|
Resverlogix Corp.
|
Jun 22, 2020 01:20PM
|
|
Re: National Kidney Foundation -Abstract: BOM
|
9
|
Resverlogix Corp.
|
Mar 30, 2020 04:00PM
|
|
The problem...as I see it
|
9
|
Resverlogix Corp.
|
Oct 16, 2020 12:40PM
|
|
Re: "Stem Cells and Synthetic Biology” Featuring Dr. Krishanu Saha
|
9
|
Resverlogix Corp.
|
Apr 20, 2021 09:11PM
|
|
Re: The cardiac pre-print now published....in Cell!
|
9
|
Resverlogix Corp.
|
Mar 16, 2021 06:39PM
|
|
Opportunity Cost
|
9
|
Resverlogix Corp.
|
Feb 02, 2021 09:23AM
|
|
Re: Nature Article on the role of Endothelial Cells in COVID 19 - more stuff
|
9
|
Resverlogix Corp.
|
May 31, 2020 04:35PM
|
|
News! - COVID 19 pre-clinical and clinical research trials
|
9
|
Resverlogix Corp.
|
Jun 01, 2020 08:38AM
|
|
Nature Article on the role of Endothelial Cells in COVID 19
|
9
|
Resverlogix Corp.
|
May 21, 2020 08:41AM
|
|
Re: Tweet from Prof Kausik Ray
|
9
|
Resverlogix Corp.
|
Jun 01, 2020 10:45AM
|
|
Re: Todays presentation - Archman and paladin
|
9
|
Resverlogix Corp.
|
May 12, 2021 02:38PM
|
|
Re: New-Report of exempt distribution
|
10
|
Resverlogix Corp.
|
Jan 05, 2021 05:40PM
|
|
Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study
|
10
|
Resverlogix Corp.
|
Jun 22, 2020 10:42PM
|
